An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia

被引:67
作者
Johansson, PL [1 ]
Safai-Kutti, S [1 ]
Kutti, J [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Med, Haematol & Coagulat Sect, S-41345 Gothenburg, Sweden
关键词
polycythaemia vera; apparent polycythaemia; absolute erythrocytosis; haemoglobin; haematocrit;
D O I
10.1111/j.1365-2141.2005.05517.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis of polycythaemia vera (PV) has been established upon sets of Clinical criteria, which require the presence of absolute erythrocytosis (AE). The most recent clinical criteria for PV, published by the World Health Organization (WHO) in 2001, also required AE, and stated that the measured red cell mass (RCM) could be replaced by a surrogate marker for AE; a haemoglobin (Hb) value of >18.5 g/dl in males and >16.5 g/dl in females. The present study evaluated the potential of venous haematocrit (Hct) and Hb values as possible surrogate markers for AE in a series of 77 consecutive patients with PV and 66 patients with apparent polycythaemia (AP), in all of whom the RCM had been previously determined. In only 35% of the male PV patients would Hb values >18.5 g/dl indicate the presence of AE. Conversely, 14% of male AP patients would be misdiagnosed as having AE. A Hb > 16.5 g/dl would predict the presence of AE in 63% of the female PV patients, but 35% of female AP cases would be misdiagnosed as having AE. However, when the Hct was >= 0.60 an AE was always present, and this was true for both male and female subjects.
引用
收藏
页码:701 / 705
页数:5
相关论文
共 15 条
  • [1] BERK PD, 1986, SEMIN HEMATOL, V23, P132
  • [2] BERLIN NI, 1975, SEMIN HEMATOL, V12, P339
  • [3] Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia
    Johansson, P
    Safai-Kutti, S
    Lindstedt, G
    Suurküla, M
    Kutti, J
    [J]. ACTA HAEMATOLOGICA, 2002, 108 (01) : 1 - 7
  • [4] On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Vastra Gotaland region, Sweden
    Johansson, P
    Andréasson, B
    Safai-Kutti, S
    Rhedin, C
    Vilén, L
    Väärt, J
    Kutti, J
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 251 (04) : 348 - 354
  • [5] Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis
    Klippel, S
    Strunck, E
    Temerinac, S
    Bench, AJ
    Meinhardt, G
    Mohr, U
    Leichtle, R
    Green, AR
    Griesshammer, M
    Heimpel, H
    Pahl, HL
    [J]. BLOOD, 2003, 102 (10) : 3569 - 3574
  • [6] MESSINEZY M, 1993, EUR J HAEMATOL, V51, P125
  • [7] Clinical spectrum of Leishmaniasis
    Pearson, RD
    Sousa, AD
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) : 1 - 11
  • [8] PEARSON TC, 1984, CLIN LAB HAEMATOL, V6, P207
  • [9] APPARENT POLYCYTHEMIA
    PEARSON, TC
    [J]. BLOOD REVIEWS, 1991, 5 (04) : 205 - 213
  • [10] PEARSON TC, 1984, SCAND J HAEMATOL, V33, P68